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Abstract
Introduction—Carcinogen exposure and unhealthy habits acquired in young adulthood can set 
the stage for the development of cancer at older ages. This study measured the current prevalence 
of several cancer risk factors among young adults to assess opportunities to intervene to change 
the prevalence of these risk factors and potentially reduce cancer incidence.
Methods—Using 2015 National Health Interview Survey data (analyzed in 2016), the prevalence 
of potential cancer risk factors was estimated among U.S. adults aged 18–44 years, based on 
responses to questions about diet, physical activity, tobacco product use, alcohol, indoor tanning, 
sleep, human papillomavirus vaccine receipt, and obesity, stratified by sex, age, and race/ethnicity.
Results—The prevalence of some risk factors varied by age and race/ethnicity. Obesity (one in 
four people) and insufficient sleep (one in three people) were common among men and women. 
Physical inactivity (one in five men, one in four women); binge drinking (one in four men, one in 
eight women); cigarette smoking (one in five men, one in seven women); and frequent 
consumption of red meat (one in four men, one in six women) also were common. More than half 
of the population of adults aged 18–44 years consumed sugar-sweetened beverages daily and 
processed meat at least once a week. Most young adults had never had the human papillomavirus 
vaccine.
Conclusions—Findings can be used to target evidence-based environmental and policy 
interventions to reduce the prevalence of cancer risk factors among young adults and prevent the 
development of future cancers.
INTRODUCTION
Most cancers are thought to be caused by a combination of factors operating over a person’s 
lifetime.1,2 Approaches to cancer prevention need to address the changing exposome of non-
genetic exposures over time.3 Actions to reduce the prevalence of harmful risk factors 
among young adults could prevent or delay the development of new cancer cases in the 
future,4–7 as well as prevent other chronic diseases.8
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The 2015 National Health Interview Survey included measures of several factors that could 
contribute to increased risk for one or more types of cancer. These include indoor tanning9; 
e-cigarette use10–12; cigarette smoking13; binge drinking14; frequent consumption of red and 
processed meats15; obesity16; lack of human papillomavirus (HPV) vaccination17; 
insufficient sleep18,19; physical inactivity20,21; and daily consumption of sugar-sweetened 
beverages (SSBs).22,23 Current information on the prevalence of these potentially modifiable 
factors among young adults is essential for planning and targeting efforts to reduce long-
term cancer incidence rates. This study estimated the current prevalence of common cancer 
risk factors among young adults, aged 18–44 years, stratified by sex, age, and race/ethnicity.
METHODS
Data Sample
Data came from the 2015 National Health Interview Survey, a cross-sectional household 
survey, conducted in person in English or Spanish and representative of the civilian, non-
institutionalized U.S. population.24 Additional information was collected from a randomly 
selected adult (aged ≥18 years), and the final response rate for this section was 55.2%, 
taking household nonresponse into account.24 Respondents who reported a history of cancer 
other than non-melanoma skin cancer were excluded (n=240), leaving 6,384 men and 7,333 
women aged 18–44 years for analysis. Analyses by race/ethnicity were limited to non-
Hispanic white, non-Hispanic black, and Hispanic to yield adequate sample sizes for stable 
subgroup estimates. Prevalence estimates for the HPV vaccine were limited to adults aged 
18–26 years.17,25
Measures
Variables were treated as dichotomous and sample file recodes used for questionnaire 
items24 unless otherwise noted. Obesity was defined as BMI ≥30.2627, Current cigarette 
smokers reported smoking ≥100 cigarettes during their lifetimes and smoking every day or 
some days; e-cigarette use included both every day and some day. Binge drinking was 
defined as four or more alcoholic drinks for women or five or more drinks for men on an 
occasion during the past 30 days.2228, 29, Indoor tanning was defined as use of a tanning 
device during the past 12 months. Never receiving the HPV vaccine was defined as not 
receiving one or more shots. Insufficient sleep was defined as <7 hours of sleep/24-hour 
period on average.19 Physical inactivity was defined as not reporting any activity when 
queried about light- to moderate-intensity or vigorous-intensity leisure-time physical activity 
of ≥10 minutes at a time.30 Consumption of specific foods with a frequency inconsistent 
with cancer prevention recommendations was defined as daily SSB consumption (one or 
more times/day), red meat five or more times/week, and processed meat one or more times/ 
week.29
Statistical Analysis
Weighted proportions and 95% CIs were calculated for populations by sex, age, and race/
ethnicity in 2015, using SAS, version 9.3, with SUDAAN, version 11, to adjust for the 
complex sampling design.24
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RESULTS
Obesity (one in four people) and insufficient sleep (one in three people) were prevalent 
among men (Table 1) and women (Table 2). Other common risk factors included physical 
inactivity (i.e., no light- to moderate-intensity or vigorous-intensity leisure-time physical 
activity ≥10 minutes at a time; one in five men, one in four women); binge drinking (one in 
four men, one in eight women); cigarette smoking (one in five men, one in seven women); 
and frequent consumption of red meat (one in four men, one in six women). More than half 
consumed SSBs daily and processed meat at least once a week. The prevalence of some risk 
factors varied by age and race/ethnicity.
Among adults aged ≤26 years, the proportion who never had the HPV vaccine was 57.9% 
(95% CI=54.6%, 61.2%) for women aged 18–26 years, 79.0% (95% CI=73.7%, 83.5%) for 
men aged 18–21 years, and 86.4% (95% CI= 69.7%, 94.7%) for gay or bisexual men aged 
22–26 years.
DISCUSSION
Young adulthood is recognized as a period of pivotal life transitions and health vulnerability.
31,32
 These data from 2015 on the prevalence of common cancer risk factors can inform and 
support efforts by healthcare providers and public health professionals to prevent cancer and 
other chronic diseases in this generation of young adults. Successful prevention strategies 
include community-wide approaches to reduce risk.33
Overall, about one in four young adult men and women are obese; this proportion varied by 
age and race/ethnicity. Increased cancer risk also has been reported at excess weight levels 
below this definition of obesity.34 Recommended strategies to prevent excess weight gain 
focus on policy and environmental changes such as increasing access to affordable healthy 
food options and safe opportunities for physical activity.35
The prevalence of cigarette smoking and e-cigarette use was higher for men than women. 
Cigarette smoking has declined by 46.6% over the past decade among young adults aged 
18–24 years and by 26.2% among adults aged 25–44 years.36 Behavioral change is possible 
with the implementation of approaches that operate at multiple levels and include context-
changing interventions, such as tobacco tax increases and indoor air policies.37
Binge drinking was reported by one in four men and one in eight women, and was highest 
among white men aged 25–29 years. Although the risk of cancer tends to be higher among 
excessive drinkers, cancer risk increases with any alcohol consumption.14 Adherence to the 
Dietary Guidelines on alcohol28 can be improved by implementing evidence-based strategies 
to prevent excessive alcohol consumption, such as those in the Community Guide.38,39
Cancer prevention guidelines recommend limiting SSB consumption to prevent weight gain 
without specifying a limit.22,29 These data demonstrate that daily SSB consumption was the 
norm across all sex, age, and race/ ethnicity groups, and was highest among Hispanic men. 
High intake of added sugars has been associated with obesity and an increased risk for some 
types of cancer.40–42
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Indoor tanning was highest among white women. Indoor tanning has been declining among 
adults, possibly because of increased awareness about the danger posed by ultraviolet 
radiation.43 The recent Surgeon General’s Call to Action to Prevent Skin Cancer outlines 
several strategies to reduce harms from indoor tanning, including organizational policies to 
discourage indoor tanning by students on college campuses.44
Many young men and women reported being physically inactive, a risk factor for some 
forms of cancer, particularly colon and breast cancers.21 Adults who are physically inactive 
and those who are insufficiently active (some activity but not meeting the guideline) can 
increase health benefits by working toward meeting the aerobic physical activity guideline.21 
Step it Up! The Surgeon General’s Call to Action to Promote Walking and Walkable 
Communities outlines several community-based strategies to better support walking and 
walkability for all people.45
Within the recommended age ranges for the HPV vaccine, men were more likely never to 
have received the HPV vaccine than women. Routine HPV vaccination is recommended at 
age 11 or 12 years.17 HPV vaccination is also recommended for women up to age 26 years, 
men up to age 21 years, and men who have sex with men up to age 26 years who were not 
previously vaccinated.25 Even though the HPV vaccine is most effective when administered 
to young adolescents, many young adults have never received the HPV vaccine and could 
potentially benefit from catch-up vaccination.
Limitations
Findings are subject to several limitations. All measures are subject to potential reporting 
bias. The strength of evidence is not equal across risk factors and may vary by cancer type. 
Many cancer risk factors were not measured. Cut points do not reflect thresholds for cancer 
risk. Small sample sizes for many strata yielded unstable estimates.
CONCLUSIONS
Many modifiable cancer risk factors are common among young adults in the U.S. The 
implementation of policy and environmental strategies for these risk factors could prevent 
future cancers.
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